Pantoprazole 20/40 mg in Reflux-Associated Complaints With Focus on Gastrointestinal Symptoms
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- Nycomed
- 入组人数
- 4,188
- 试验地点
- 1
- 主要终点
- Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn
研究概览
简要总结
The aim of this study was to evaluate the effect of 14 days treatment with Pantoprazole 40 mg and 20 mg on gastroesophageal reflux disease (GERD) related symptoms in a large patient population.
研究设计
- 研究类型
- Observational
- 观察模型
- Cohort
- 时间视角
- Prospective
入排标准
- 年龄范围
- 12 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- 未提供
排除标准
- 未提供
研究组 & 干预措施
Group 1
All patients enrolled
干预措施: Pantoprazole (Drug)
结局指标
主要结局
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Heartburn
时间窗: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Eructation/Sour Eructation
时间窗: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Reflux-associated Gastrointestinal Symptoms: Assessment of the Severity of Painful Swallowing
时间窗: 14 days
Physician's assessment on a scale with 1=none, 2=mild, 3=moderate, 4=severe
Assessment of Pantoprazole at Final Visit: Efficacy Regarding Reflux Symptoms
时间窗: 14 days
Physician's assessment on a scale with 1=excellent, 2=good, 3=satisfactory, 4=not satisfactory
次要结局
- Functional Dyspepsia Symptoms: Assessment of the Severity of Upper Abdominal Pain(14 days)
- Functional Dyspepsia Symptoms: Assessment of the Severity of Sensation of Fullness(14 days)
- Functional Dyspepsia Symptoms: Assessment of the Severity of Nausea(14 days)
- Assessment of Pantoprazole at Final Visit: Efficacy Regarding Dyspeptic Symptoms(14 days)
- Irritable Bowel Syndrome: Assessment of the Severity of Lower Abdominal Pain(14 days)
- Irritable Bowel Syndrome: Assessment of the Severity of Diarrhoea(14 days)
- Irritable Bowel Syndrome: Assessment of the Severity of Constipation(14 days)
- Assessment of Pantoprazole at Final Visit: Efficacy Regarding Irritable Bowel Syndrome(14 days)
- Assessment of the Tolerability of Pantoprazole at Final Visit(14 days)